Lawsuit Against Gilead Sciences High Prices For Sovaldi In The U.S.
Hepatitis C, News
A lawsuit was recently filed by a Philadelphia-area law firm against Gilead Sciences, Inc. (“Gilead”) on behalf of the Southeastern Pennsylvania Transportation Authority (“SEPTA”) due to the sale and pricing of Sovaldi®, Gilead’s groundbreaking Hepatitis C drug. Sovaldi is ... Read more